| Andrew R Freedman, MD | |
|
7 Centre Dr Ste 11, Monroe Township, NJ 08831-1565 | |
| (732) 412-3515 | |
| (732) 412-3519 |
| Full Name | Andrew R Freedman |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 45 Years |
| Location | 7 Centre Dr Ste 11, Monroe Township, New Jersey |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598766743 | NPI | - | NPPES |
| 1173405 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 25MA03772700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barton Memorial Hospital | South lake tahoe, CA | Hospital |
| Evanston Regional Hospital | Evanston, WY | Hospital |
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| Robert Wood Johnson University Hospital At Hamilton | Hamilton, NJ | Hospital |
| Entity Name | Evanston Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013288836 PECOS PAC ID: 7113900358 Enrollment ID: O20180823002979 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Pulmonary And Sleep Medicine Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295298016 PECOS PAC ID: 8729310297 Enrollment ID: O20191101002198 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Proctor Health Systems |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134173917 PECOS PAC ID: 3476440173 Enrollment ID: O20200417000826 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Aretaeus Telemedicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548490261 PECOS PAC ID: 6002953635 Enrollment ID: O20210215001213 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20210827000881 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Trinity Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568414134 PECOS PAC ID: 2264337518 Enrollment ID: O20220428002152 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | St Mary's Hospital Medical Center Of Green Bay Inc-hospital Sisters |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649246877 PECOS PAC ID: 7719871268 Enrollment ID: O20220428002838 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | St. Nicholas Hospital-sisters Of The Third Order Of St Francis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447737762 PECOS PAC ID: 8325931652 Enrollment ID: O20220506001764 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | St Vincent Hospital-hospital Sisters-third Order Of St Francis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689694911 PECOS PAC ID: 5799694675 Enrollment ID: O20220506001907 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Trinity Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073594156 PECOS PAC ID: 7315858529 Enrollment ID: O20220523001677 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Methodist Medical Center Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184670663 PECOS PAC ID: 1355259714 Enrollment ID: O20220525002964 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Entity Name | Northwest Iowa Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215962550 PECOS PAC ID: 0749198026 Enrollment ID: O20231022000029 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew R Freedman, MD 7 Marshall Dr, Edison, NJ 08817-2910 Ph: (732) 632-7892 | Andrew R Freedman, MD 7 Centre Dr Ste 11, Monroe Township, NJ 08831-1565 Ph: (732) 412-3515 |
News Archive
Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.
Ardea Biosciences, Inc. (Nasdaq: RDEA) a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV), reported recent accomplishments, announced fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance for 2010.
The annoying bulges of an overwound telephone cord that shorten its reach and limit a caller's motion help explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators led by Mary-Ann Bjornsti, Ph.D., at St. Jude Children's Research Hospital, and Nynke Dekker, Ph.D., at Delft Technology University.
Kaiser Health News staff writer Jordan Rau reports: "More than 2,000 hospitals -; including some nationally recognized ones -; will be penalized by the government starting in October because many of their patients are readmitted soon after discharge, new records show".
BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that two human embryonic stem (hES) cell lines, ESI-014 and ESI-017, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.
› Verified 1 days ago
Dr. Manuel T Amendo, M.D. F.A.C.C. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 11 Centre Dr, Monroe Township, NJ 08831 Phone: 609-655-3800 Fax: 609-655-5203 | |
Dr. Mohammad Faizan Anwar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 32 England Rd, Monroe Township, NJ 08831 Phone: 347-860-1873 | |
Mr. John Anthony Verdoni, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 312 Applegarth Rd Ste 107, Monroe Township, NJ 08831 Phone: 609-395-2939 Fax: 609-395-4179 | |
Keith Ira Sherrow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Perrineville Rd, Suite 25, Monroe Township, NJ 08831 Phone: 609-655-1945 Fax: 609-655-1967 | |
Stuart Rubenstein, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 29 Harwood Road, Monroe Township, NJ 08831 Phone: 609-409-2091 Fax: 609-409-1167 | |
Dr. Linda Z Korman, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 350 Sunrise Way, Monroe Township, NJ 08831 Phone: 732-261-7209 | |
Dr. Jose Carlos Vigario, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Centre Dr, Suite 200, Monroe Township, NJ 08831 Phone: 609-395-2470 Fax: 609-860-5288 |